QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Aldoxorubicin HCl|BIOLOGICAL: N-803|BIOLOGICAL: ETBX-011|BIOLOGICAL: ETBX-051|BIOLOGICAL: ETBX-061|BIOLOGICAL: GI-4000|BIOLOGICAL: GI-6207|BIOLOGICAL: GI-6301|BIOLOGICAL: haNK for Infusion|BIOLOGICAL: avelumab|BIOLOGICAL: bevacizumab|DRUG: Capecitabine|DRUG: Cisplatin|DRUG: Cyclophosphamide|DRUG: 5-Fluorouracil|DRUG: Leucovorin|DRUG: nab-Paclitaxel|PROCEDURE: SBRT
Sponsor: ImmunityBio, Inc.